Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348335 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Topical Cyclosporin for Ocular Rosacea
A Phase 4 study, sponsored by Ophthalmic Consultants of Long Island.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT00348335 is a Phase 4 study that has completed, run by Ophthalmic Consultants of Long Island. The registered enrollment target is 35 participants.
The verdict
NCT00348335, a Phase 4 study, has completed, sponsored by Ophthalmic Consultants of Long Island.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
Interventions
- DRUG Cyclosporine 0.05%
- DRUG Ocular lubricant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348335
The ClinicalTrials.gov registry entry for NCT00348335 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ophthalmic Consultants of Long Island, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cyclosporine 0.05% is the first listed.
NCT00348335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00348335 about?
NCT00348335 is a clinical study titled "Efficacy of Topical Cyclosporin for Ocular Rosacea". The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
What is the current status of trial NCT00348335?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2006-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00348335?
The interventions under investigation include: Cyclosporine 0.05% (DRUG), Ocular lubricant (DRUG).
Who is sponsoring clinical trial NCT00348335?
This trial is sponsored by Ophthalmic Consultants of Long Island, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.